10th Anniversary Anti-Cancer Challenge SATURDAY, OCTOBER 10
Register and choose your activity; Create or join a team; Donate or join as a virtual participant; anti-cancerchallenge.org
Melanoma Research Program FY26
Up to 4 years | Up to $2,800,000 Rare Melanoma Research Support. Deadline: July 13, 2026
Arnold & Mabel Beckman Young Investigator Program
4 years | Up tp $600,000 Supports early-career faculty in the chemical and life sciences. Deadline: July 31, 2026
Mike Slive Foundation 2026-27 Pilot Research Grant
1 year | Up to $50,000 Prostate Cancer Research Support. Deadline: September 7, 2026
Research Support Opportunity
1 year | $2,500 UC Irvine Genetic Epidemiology Research Institute Funds research using NIH All of Us data to advance precision medicine. Rolling Deadline
A1 Bridge Funding
1 year | $20,000 UC Irvine Chao Family Comprehensive Cancer Center Supports cancer research with strong potential to improve treatment, diagnosis, prevention, and patient outcomes. Designed to strengthen and resubmit NIH grant applications. Rolling Deadline
👏 Congratulations to Rachel Silverio on Her Promotion!
Rachel has been promoted to Research Data Coordinator for Team F after consistently ensuring the accuracy, quality, and integrity of clinical research data across Phase I–III industrial, institutional, and national trials, while supporting colleagues and helping optimize data management workflows. rsilveri@hs.uci.edu
📣Help Improve Cancer Center Shared Resources - Complete the Survey by July 10
Please take a few minutes to share your feedback.
Your input will help us identify what is working well, prioritize improvements and services, and strengthen our shared resource core facilities.
After a few basic questions, you will only be asked about the Shared Resources used by you and your team. The survey is anonymous.
Thank you for helping us improve the facilities and services that support your cancer research.
📣 Office of Community Outreach and Engagement (COE)
Strengthen your research impact, enhance clinical trial success, gain trusted community insights, increase study relevance, and accelerate accruals.
Member, Catherine Coombs, MD
Experts Weigh Fixed-Duration Approaches in Frontline CLL
Director, Rick Van Etten, MD, PhD; Member, Jennifer Valerin, MD, PhD
ASCO 2026 Pancreatic Cancer Updates
Member, Maheshwari Senthil, MD
STOPGAP II - A National Randomized Clinical Trial for Patients with Stage 4 Gastric Cancer
Member, Lbachir Benmohamed, PhD
Artificial Intelligence Could Usher in a New Era of Vaccine Development